🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.4223
+0.0134 (3.28%)
At close: Nov 19, 2026, 4:00 PM EST
0.4220
-0.0003 (-0.07%)
After-hours: Nov 19, 2026, 7:58 PM EST

Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $117.26 million. The enterprise value is $164.77 million.

Market Cap117.26M
Enterprise Value 164.77M

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

AKBA has 277.66 million shares outstanding. The number of shares has increased by 9.89% in one year.

Current Share Class 277.66M
Shares Outstanding 277.66M
Shares Change (YoY) +9.89%
Shares Change (QoQ) +2.69%
Owned by Insiders (%) 1.75%
Owned by Institutions (%) 41.34%
Float 272.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.59
Forward PS 1.16
PB Ratio 5.75
P/TBV Ratio n/a
P/FCF Ratio 8.46
P/OCF Ratio 7.43
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.84
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 11.89

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 10.15.

Current Ratio 1.36
Quick Ratio 1.21
Debt / Equity 10.15
Debt / EBITDA n/a
Debt / FCF 14.92
Interest Coverage -1.28

Financial Efficiency

Return on equity (ROE) is -143.83% and return on invested capital (ROIC) is -5.37%.

Return on Equity (ROE) -143.83%
Return on Assets (ROA) -3.56%
Return on Invested Capital (ROIC) -5.37%
Return on Capital Employed (ROCE) -11.18%
Weighted Average Cost of Capital (WACC) 5.82%
Revenue Per Employee $1.02M
Profits Per Employee -$229,691
Employee Count194
Asset Turnover 0.56
Inventory Turnover 2.00

Taxes

In the past 12 months, AKBA has paid $1.38 million in taxes.

Income Tax 1.38M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.41% in the last 52 weeks. The beta is 0.23, so AKBA's price volatility has been lower than the market average.

Beta (5Y) 0.23
52-Week Price Change -74.41%
50-Day Moving Average 0.73
200-Day Moving Average 1.09
Relative Strength Index (RSI) 34.92
Average Volume (20 Days) 7,466,796

Short Selling Information

The latest short interest is 27.20 million, so 9.80% of the outstanding shares have been sold short.

Short Interest 27.20M
Short Previous Month 23.07M
Short % of Shares Out 9.80%
Short % of Float 9.97%
Short Ratio (days to cover) 3.17

Income Statement

In the last 12 months, AKBA had revenue of $197.20 million and -$44.56 million in losses. Loss per share was -$0.17.

Revenue197.20M
Gross Profit 159.83M
Operating Income -20.09M
Pretax Income -43.18M
Net Income -44.56M
EBITDA -18.76M
EBIT -20.09M
Loss Per Share -$0.17
Full Income Statement

Balance Sheet

The company has $159.25 million in cash and $206.77 million in debt, with a net cash position of -$47.52 million or -$0.17 per share.

Cash & Cash Equivalents 159.25M
Total Debt 206.77M
Net Cash -47.52M
Net Cash Per Share -$0.17
Equity (Book Value) 20.37M
Book Value Per Share 0.07
Working Capital 58.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $15.78 million and capital expenditures -$1.92 million, giving a free cash flow of $13.86 million.

Operating Cash Flow 15.78M
Capital Expenditures -1.92M
Depreciation & Amortization 1.34M
Net Borrowing -19.58M
Free Cash Flow 13.86M
FCF Per Share $0.05
Full Cash Flow Statement

Margins

Gross margin is 81.05%, with operating and profit margins of -10.19% and -22.60%.

Gross Margin 81.05%
Operating Margin -10.19%
Pretax Margin -21.90%
Profit Margin -22.60%
EBITDA Margin -9.51%
EBIT Margin -10.19%
FCF Margin 7.03%

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -9.89%
Shareholder Yield -9.89%
Earnings Yield -40.18%
FCF Yield 11.82%

Analyst Forecast

The average price target for AKBA is $2.67, which is 531.54% higher than the current price. The consensus rating is "Buy".

Price Target $2.67
Price Target Difference 531.54%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (3Y) -22.99%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AKBA has an Altman Z-Score of -5.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.72
Piotroski F-Score 3